TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | 2 | 2 | 0 | -9 | 6 | -9 | -2 |
| S | %wins | 33 | 0 | 67 | 67 | 0 | 67 | 39 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/4/15 16:01 | 9/3/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gladwell Mark | MA | O | SVP,Glob | S | -139 | 52.27 | 33 | -3 | -100 | 0 | D | 63 | 45 | 13 | 1 | 2 | -5 | 3 | 0 | 3 | 3 | -1 | -20 | 5 | -23 |
9/2/15 16:52 | 8/31/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gladwell Mark | MA | O | SVP,Glob | S.d | -1,437 | 52.23 | 33 | -28 | -91 | 3 | D | 64 | 41 | 11 | -2 | -2 | -5 | -4 | -3 | 0 | 1 | -4 | -20 | 4 | -25 |
2/25/15 16:54 | 2/23/15 | ALR | Alere Inc. | DE | Health | Diagn | In Vitro & In Vivo Diagnostic | Gladwell Mark | MA | O | SVP,Glob | S.d | -593 | 44.62 | 24 | -13 | -100 | 0 | D | 104 | 26 | 29 | 13 | 10 | 10 | 3 | 3 | 2 | 2 | 5 | 14 | 10 | 20 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |